Insight Pharmaceuticals Buys Monistat Brand

Insight Pharmaceuticals, a portfolio company of Swander Pace Capital, has acquired the Monistat North American brand portfolio from McNEIL-PPC Inc. Financial terms of the deal were not released. In connection with the transaction, Ontario Teachers' Pension Plan, through its private equity group Teachers' Private Capital, has joined Swander Pace Capital as an equity investor in Insight. HT Capital Advisors acted as exclusive financial advisor to Insight and Swander Pace Capital.

DealsNorth AmericaUSBriefs